Combination therapy with macitentan and phosphodiesterase type-5 inhibitor (PDE5i) in pulmonary arterial hypertension (PAH): real-world data from OPUS and OrPHeUS

被引：0
|
作者：
McLaughlin, V [1 ]
Channick, R. [2 ]
Kim, N. H. [3 ]
Flynn, M. [4 ]
Leroy, S. [5 ]
Wetherill, G. [5 ]
Chin, K. [6 ]
机构：
[1] Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[3] Univ Calif San Diego, San Diego, CA 92103 USA
[4] Actel Pharmaceut US Inc, San Francisco, CA USA
[5] Actel Pharmaceut Ltd, Allschwil, Switzerland
[6] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
来源：
EUROPEAN HEART JOURNAL | 2020年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2297 / 2297
页数：1
相关论文
共 50 条
  • [1] Macitentan in incident and prevalent pulmonary arterial hypertension (PAH): OPUS/OrPHeUS real-world data
    Melendres-Groves, Lana
    Channick, Richard
    Chin, Kelly
    Mclaughlin, Vallerie V.
    Flynn, Megan
    Ong, Rose
    Wetherill, Graham
    Kim, Nick H.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [2] Real-World Upfront Combination Therapy with Macitentan and Tadalafil in Pulmonary Arterial Hypertension (PAH): Data from the Combined OPUS and OrPHeUS Datasets
    Chin, K. M.
    Channick, R.
    McLaughlin, V. V.
    Melendres-Groves, L.
    Flynn, M.
    Leroy, S.
    Wetherill, G.
    Kim, N. H.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [3] Concomitant initiation of combination therapy with macitentan and tadalafil in pulmonary arterial hypertension (PAH) patients with comorbidities: real-world data from OPUS and OrPHeUS
    Channick, R.
    Chin, K. M.
    Kim, N. H.
    Ong, R.
    Turricchia, S.
    Mitchell, L.
    McLaughlin, V. V.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 : 1916 - 1916
  • [4] Macitentan and Tadalafil Combination Therapy in Incident and Prevalent Pulmonary Arterial Hypertension: Real-World Evidence from the OPUS/OrPHeUS Studies
    Chin, Kelly M.
    Channick, Richard
    Kim, Nick H.
    Macdonald, Gwen
    Ong, Rose
    Martin, Nicolas
    Senatore, Assunta
    McLaughlin, Vallerie V.
    [J]. ADVANCES IN THERAPY, 2024,
  • [5] Rationale And Design Of The Replace Trial: Riociguat Replacing Phosphodiesterase 5 Inhibitor (pde5i) Therapy Evaluated Against Continued Pde5i Therapy In Patients With Pulmonary Arterial Hypertension (pah)
    Hoeper, M. M.
    Ghofrani, H. -A.
    Benza, R. L.
    Corris, P. A.
    Gibbs, S.
    Klinger, J. R.
    Langleben, D.
    McLaughlin, V. V.
    Peacock, A.
    Rosenkranz, S.
    Vonk-Noordegraaf, A.
    White, J.
    Kleinjung, F.
    Meier, C.
    Simonneau, G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [6] Macitentan in pulmonary hypertension (PH): Data from OPUS and OrPHeUS real-world data sets
    Kim, Nick
    Channick, Richard
    Chin, Kelly
    Melendres-Groves, Lana
    Ravichandran, Ashwin
    Brand, Monika
    Flynn, Megan
    Leroy, Sandrine
    Morganti, Adele
    Mclaughlin, Vallerie
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [7] Macitentan in portopulmonary hypertension (PoPH): Real-world data from OPUS and OrPHeUS
    Kim, Nick
    Chin, Kelly
    Mclaughlin, Vallerie
    Restrepo-Jaramillo, Ricardo
    Safdar, Zeenat
    Brand, Monika
    Flynn, Megan
    Leroy, Sandrine
    Morganti, Adele
    Channick, Richard
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [8] EXPERIENCE WITH MACITENTAN TRIPLE COMBINATION THERAPY IN PULMONARY ARTERIAL HYPERTENSION: REAL-WORLD EVIDENCE FROM THE OPUS REGISTRY
    McConnell, John
    Chin, Kelly
    Kim, Nick
    McLaughlin, Vallerie
    Flynn, Megan
    Ong, Rose
    Wetherill, Graham
    Channick, Richard
    [J]. CHEST, 2020, 158 (04) : 2217A - 2219A
  • [9] Treatment with macitentan for pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD): real-world experience from the combined OPUS and OrPHeUS data sets
    McLaughlin, V
    Chin, K.
    Kim, N. H.
    Flynn, M.
    Ong, R.
    Wetherill, G.
    Channick, R.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 2293 - 2293
  • [10] Macitentan in chronic thromboembolic pulmonary hypertension (CTEPH): combined data from OPUS and OrPHeUS real-world data sets
    Channick, R.
    Chin, K.
    Kim, N.
    McConnell, J.
    Poch, D.
    Flynn, M.
    Leber, L.
    Morganti, A.
    McLaughlin, V.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 2883 - 2883
12345